ZA885774B - Vaccines in which the characteristic epitope is incorporated in a protein of a picornavirus,in particular of poliovirus - Google Patents
Vaccines in which the characteristic epitope is incorporated in a protein of a picornavirus,in particular of poliovirusInfo
- Publication number
- ZA885774B ZA885774B ZA885774A ZA885774A ZA885774B ZA 885774 B ZA885774 B ZA 885774B ZA 885774 A ZA885774 A ZA 885774A ZA 885774 A ZA885774 A ZA 885774A ZA 885774 B ZA885774 B ZA 885774B
- Authority
- ZA
- South Africa
- Prior art keywords
- picornavirus
- poliovirus
- vaccines
- protein
- incorporated
- Prior art date
Links
- 241000991587 Enterovirus C Species 0.000 title 1
- 241000709664 Picornaviridae Species 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8711337A FR2619012B1 (fr) | 1987-08-07 | 1987-08-07 | Vaccins dont l'epitope caracteristique est incorpore dans une proteine de picornavirus, notamment de poliovirus |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA885774B true ZA885774B (en) | 1989-04-26 |
Family
ID=9354047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA885774A ZA885774B (en) | 1987-08-07 | 1988-08-05 | Vaccines in which the characteristic epitope is incorporated in a protein of a picornavirus,in particular of poliovirus |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0302801B1 (pt) |
JP (1) | JPH01157380A (pt) |
AR (1) | AR242057A1 (pt) |
AT (1) | ATE129288T1 (pt) |
DE (1) | DE3854591D1 (pt) |
DK (1) | DK438288A (pt) |
FR (1) | FR2619012B1 (pt) |
OA (1) | OA08749A (pt) |
PT (1) | PT88219B (pt) |
WO (1) | WO1989001516A1 (pt) |
ZA (1) | ZA885774B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747324A (en) * | 1988-06-10 | 1998-05-05 | Therion Biologics Corporation | Self-assembled, defective, non-self-propagating lentivirus particles |
US5614404A (en) * | 1988-06-10 | 1997-03-25 | Theriod Biologics, Incorporated | Self-assembled, defective, non-self-propagating lentivirus particles |
EP0436634A1 (en) * | 1988-10-03 | 1991-07-17 | Repligen Corporation | Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
GB8912496D0 (en) * | 1989-05-31 | 1989-07-19 | Medical Res Council | Vaccines |
CA2055613A1 (en) * | 1989-05-31 | 1990-12-01 | Jeffrey W. Almond | Poliovirus chimaeras |
EP0431128B1 (en) * | 1989-06-01 | 2003-03-26 | Applied Biotechnology, Inc. | Vector coding for self-assembled, defective, non-self-propagating viral particles |
US5817491A (en) * | 1990-09-21 | 1998-10-06 | The Regents Of The University Of California | VSV G pseusdotyped retroviral vectors |
DE69131908T3 (de) * | 1991-02-19 | 2008-04-03 | Oxford Biomedica (Uk) Ltd. | Viruspartikel mit veraendertem wirtspektrum |
US5512421A (en) * | 1991-02-19 | 1996-04-30 | The Regents Of The University Of California | Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
GB9125896D0 (en) * | 1991-12-05 | 1992-02-05 | Almond Jeffrey W | Bicistronic viruses |
WO1994029472A2 (en) * | 1993-06-03 | 1994-12-22 | Institut Pasteur | Mengovirus as a vector for expression of foreign polypeptides |
US6071742A (en) * | 1997-03-05 | 2000-06-06 | Board Of Regents Of The University Of Nebraska | Coxsackie virus as a vector for delivery of anti-inflammatory cytokines |
WO2000014263A2 (en) * | 1998-09-03 | 2000-03-16 | Board Of Regents, The University Of Texas System | Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them |
US8494781B2 (en) | 2003-06-06 | 2013-07-23 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
EP1771585B1 (en) | 2004-07-13 | 2012-09-26 | Gen-Probe Incorporated | Compositions and methods for detection of hepatitis a virus nucleic acid |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4593002A (en) * | 1982-01-11 | 1986-06-03 | Salk Institute Biotechnology/Industrial Associates, Inc. | Viruses with recombinant surface proteins |
-
1987
- 1987-08-07 FR FR8711337A patent/FR2619012B1/fr not_active Expired
-
1988
- 1988-08-05 EP EP88402057A patent/EP0302801B1/fr not_active Expired - Lifetime
- 1988-08-05 AT AT88402057T patent/ATE129288T1/de active
- 1988-08-05 DE DE3854591T patent/DE3854591D1/de not_active Expired - Lifetime
- 1988-08-05 WO PCT/FR1988/000409 patent/WO1989001516A1/fr unknown
- 1988-08-05 DK DK438288A patent/DK438288A/da not_active Application Discontinuation
- 1988-08-05 ZA ZA885774A patent/ZA885774B/xx unknown
- 1988-08-08 OA OA59402A patent/OA08749A/xx unknown
- 1988-08-08 PT PT88219A patent/PT88219B/pt not_active IP Right Cessation
- 1988-08-08 AR AR88311618A patent/AR242057A1/es active
- 1988-08-08 JP JP63197810A patent/JPH01157380A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AR242057A1 (es) | 1993-02-26 |
FR2619012B1 (fr) | 1989-12-22 |
FR2619012A1 (fr) | 1989-02-10 |
DE3854591D1 (de) | 1995-11-23 |
EP0302801A1 (fr) | 1989-02-08 |
ATE129288T1 (de) | 1995-11-15 |
JPH01157380A (ja) | 1989-06-20 |
PT88219A (pt) | 1989-06-30 |
EP0302801B1 (fr) | 1995-10-18 |
OA08749A (fr) | 1989-03-31 |
PT88219B (pt) | 1995-09-12 |
DK438288A (da) | 1989-04-10 |
DK438288D0 (da) | 1988-08-05 |
WO1989001516A1 (fr) | 1989-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8907914D0 (en) | Vaccine preparation | |
DK628488A (da) | Stabilt mikroemulsion-rensemiddel og fremgangsmaade til fremstilling deraf samt dets anvendelse | |
AU569946B2 (en) | Multivalent pneumococcal vaccine | |
EP0391997A4 (en) | Vaccine | |
ZA885774B (en) | Vaccines in which the characteristic epitope is incorporated in a protein of a picornavirus,in particular of poliovirus | |
ZA88149B (en) | Anti-reproductive vaccines | |
GB8921470D0 (en) | Vaccines | |
GB8702691D0 (en) | Vaccines | |
EP0427768A4 (en) | Polypeptide pertussis toxin vaccine | |
ZW22487A1 (en) | Vaccine | |
DK698188D0 (da) | Peptider, deres fremstilling og anvendelse | |
ZA892954B (en) | A synthetic vaccine against foot and mouth disease and a process for the preparation thereof | |
IL90570A0 (en) | Novel insecticidal dibenzoyl-tertbutylcarbazonitrile compounds and method for the preparation thereof | |
NZ223624A (en) | Peptide immunogen from streptococcus mutans, vaccines and antibodies | |
PT87935A (pt) | A process for the preparation multivalent meningococcal class 1outer-membrane protein vaccines | |
AU2269188A (en) | Vaccines whose characteristic epitope is incorporated into a protein of picornavirus, in particular, poliovirus | |
GB8819836D0 (en) | Vaccine | |
ZW11387A1 (en) | Novel vaccines | |
GB2248186B (en) | Preparation of vaccines | |
EP0453452A4 (en) | Vaccine | |
GB8804688D0 (en) | Vaccines | |
GB8621081D0 (en) | Vaccines | |
GB8828523D0 (en) | St-lt recombinant antigen vaccines | |
IE880547L (en) | Synthetic anti-caries vaccine | |
GB8706836D0 (en) | Vaccines |